Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Skin Neoplasms 1Sezary Syndrome 1Sarcoma, Kaposi 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Nerve Tissue 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Breast Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

pembrolizumab 3fludarabine 3Cyclophosphamide 3Ipilimumab 2smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1sargramostim 1reolysin 1poly ICLC 1peginterferon alfa-2a 1osimertinib 1gusacitinib 1fludarabine phosphate 1eprenetapopt 1epacadostat 1dabrafenib 1cobimetinib 1cemiplimab 1Vorinostat 1Temozolomide 1Radiotherapy 1Radiation 1Poly I-C 1Nivolumab 1Monatide (IMS 3015) 1Methods 1MAPRE1 protein, human 1Interleukin-2 1Interleukin-15 1Interleukin-12 1IT-101 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Skin Neoplasms × Interleukin-12 × Clear all
NCT00019188 2024-03-04

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 1/2 Completed
DermatologicSarcoma

AIDS-related Kaposi sarcoma, Neoplasms, Sarcoma, Kaposi, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡